Over 25 years of experience in product development and commercialization in pharmaceutical, biotechnology and life science industries. Experienced entrepreneur in funding, management and development of international pharmaceutical and service companies. Leader of large scale business redesign projects at pharmaceutical and biotechnology companies. Focus on organizational growth and development through mergers, acquistion and development of new products, services and technology. Focus on clinical development, rare/orphan drug development, regulatory strategy, health technology assessment, product reimbursement, pharmaco-epidemiology, real world evidence, product safety, post-marketing surveillance and product risk management.

Chief Scientific Officer @ Responsible for development of corporate business, scientific and technology partnerships with industry, service providers and academia for Mapi group companies. Scientific leadership in the development of new service areas and applications of technology. International business development of functional outsourcing agreements with health care companies. From April 2008 to Present (7 years 9 months) Consultant @ From July 2006 to December 2015 (9 years 6 months) Consultant @ From August 2011 to April 2015 (3 years 9 months) Consultant @ From August 2010 to March 2014 (3 years 8 months) Consultant @ From April 2009 to June 2011 (2 years 3 months) Consultant @ From 2007 to 2010 (3 years) Consultant @ From 2006 to 2010 (4 years) Senior Director, Epidemiology & Pharmacoeconomics Department @ From February 2005 to February 2008 (3 years 1 month) Group Director, Epidemiology @ From August 1997 to February 2005 (7 years 7 months) Epidemiologist @ From 1996 to 1997 (1 year)

PgD, Organisational Development/Tavistock Institute @ City University London From 2007 to 2009 MPH, Epidemiology, Biostatistics @ San Diego State University-California State UniversityBachelor's degree, Biochemistry and Cell Biology @ University of California, San DiegoPhD, Epidemiology @ University of North Carolina at Chapel Hill Will Maier is skilled in: Pharmacovigilance, Outcomes Research, Epidemiology, Pharmaceutical Industry, Clinical Development, Infectious Diseases, Biotechnology, Life Sciences, Oncology, CRO, Drug Development, Pharmacoeconomics, FDA, Immunology, Lifesciences